生物
细胞生物学
T细胞
细胞毒性T细胞
淋巴细胞性脉络膜脑膜炎
癌症研究
效应器
CD8型
免疫系统
免疫学
生物化学
体外
作者
Sairy Hernandez,Qing Jing,Rebecca Hong Thibodeau,Xiangnan Du,Summer Park,Hyang-Mi Lee,Min Xu,Soyoung Oh,Armando Navarro,Meron Roose-Girma,Robert Newman,Søren Warming,Michelle Nannini,Deepak Sampath,Jeong Kim,Jane L. Grogan,Ira Mellman
出处
期刊:Cell Reports
[Elsevier]
日期:2018-10-01
卷期号:25 (1): 80-94
被引量:75
标识
DOI:10.1016/j.celrep.2018.09.012
摘要
We examined hematopoietic protein kinase 1 (HPK1), whose reliance on scaffold versus kinase functions for negative immune cell regulation is poorly understood and critical to its assessment as a viable drug target. We identify kinase-dependent roles for HPK1 in CD8 T cells that restrict their anti-viral and anti-tumor responses by using HPK1 kinase-dead (HPK1.kd) knockin mice. Loss of HPK1 kinase function enhanced T cell receptor signaling and cytokine secretion in a T-cell-intrinsic manner. In response to chronic lymphocytic choriomeningitis virus (LCMV) infection or tumor challenge, viral clearance and tumor growth inhibition were enhanced in HPK1.kd mice, accompanied by an increase in effector CD8 T cell function. Co-blockade of PD-L1 further enhanced T effector cell function, resulting in superior anti-viral and anti-tumor immunity over single target blockade. These results identify the importance of HPK1 kinase activity in the negative regulation of CD8 effector functions, implicating its potential as a cancer immunotherapy target.
科研通智能强力驱动
Strongly Powered by AbleSci AI